The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

LIX.a

Respiratory tract infection incl. pneumonia

This complication was not found in every study (PMID 24485129)

Publications

Tashkin DP, Miravitlles M, Celli BR, Metzdorf N, Mueller A, Halpin DMG, Anzueto A

Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.

Respiratory research 2018 Oct 05;19;196 — 2018 Oct 05 — 196

Janson C, Johansson G, Ställberg B, Lisspers K, Olsson P, Keininger DL, Uhde M, Gutzwiller FS, Jörgensen L, Larsson K

Identifying the associated risks of pneumonia in COPD patients: ARCTIC an observational study.

Respiratory research 2018 Sep 10;19;172 — 2018 Sep 10 — 172

Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Martinez FJ, Singh D, Tabberer M, Wise RA, Pascoe SJ,

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

The New England journal of medicine 2018 May 03;378;1671-1680 — 2018 May 03 — 1671-1680

Cascini S, Kirchmayer U, Belleudi V, Bauleo L, Pistelli R, Di Martino M, Formoso G, Davoli M, Agabiti N

Inhaled Corticosteroid Use in Chronic Obstructive Pulmonary Disease and Risk of Pneumonia: A Nested Case-Control Population-based Study in Lazio (Italy)-The OUTPUL Study.

COPD 2017 Jun;14;311-317 — 2017 Jun — 311-317

Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ

The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.

International journal of chronic obstructive pulmonary disease 2016;11;2775-2783 — 2016 — 2775-2783

Suissa S, Coulombe J, Ernst P

Discontinuation of Inhaled Corticosteroids in COPD and the Risk Reduction of Pneumonia.

Chest 2015 Nov;148;1177-1183 — 2015 Nov — 1177-1183

Ernst P, Saad N, Suissa S

Inhaled corticosteroids in COPD: the clinical evidence.

The European respiratory journal 2015 Feb;45;525-37 — 2015 Feb — 525-37

Crim C, Dransfield MT, Bourbeau J, Jones PW, Hanania NA, Mahler DA, Vestbo J, Wachtel A, Martinez FJ, Barnhart F, Lettis S, Calverley PM

Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.

Annals of the American Thoracic Society 2015 Jan;12;27-34 — 2015 Jan — 27-34

DiSantostefano RL, Li H, Hinds D, Galkin DV, Rubin DB

Risk of pneumonia with inhaled corticosteroid/long-acting ?2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.

International journal of chronic obstructive pulmonary disease 2014;9;457-68 — 2014 — 457-68

Mattishent K, Thavarajah M, Blanco P, Gilbert D, Wilson AM, Loke YK

Meta-review: adverse effects of inhaled corticosteroids relevant to older patients.

Drugs 2014 Apr;74;539-47 — 2014 Apr — 539-47

Kew KM, Seniukovich A

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

The Cochrane database of systematic reviews 2014 Mar 10;;CD010115 — 2014 Mar 10 — CD010115

Suissa S, Patenaude V, Lapi F, Ernst P

Inhaled corticosteroids in COPD and the risk of serious pneumonia.

Thorax 2013 Nov;68;1029-36 — 2013 Nov — 1029-36

McKeever T, Harrison TW, Hubbard R, Shaw D

Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study.

Chest 2013 Dec;144;1788-1794 — 2013 Dec — 1788-1794

O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S

Risks of pneumonia in patients with asthma taking inhaled corticosteroids.

American journal of respiratory and critical care medicine 2011 Mar 01;183;589-95 — 2011 Mar 01 — 589-95

Ernst P, Gonzalez AV, Brassard P, Suissa S

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia.

American journal of respiratory and critical care medicine 2007 Jul 15;176;162-6 — 2007 Jul 15 — 162-6